Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children from birth up to 18 years old
- Children who have been diagnosed with Acute Lymphoblastic Leukaemia (ALL) for the first time
- Children whose leukaemia has not been treated with chemotherapy before
- Children whose leukaemia cell type is classified as FAB L1 or L2 (specific subtypes identified under a microscope — confirm with trial site)
Who may not be able to join:
- Children whose leukaemia is classified as ALL L3, also known as Burkitt type
- Children who have previously received chemotherapy for their leukaemia
- Children who have Trisomy 21 (also known as Down syndrome)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00(221)77 656 49 13.
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of these recommendations; Correct application of therapeutic recommendations; Complete Remission Rate (CR) close to 85% after induction; Ability to follow treatment:; Outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.